Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-21-000094

COO and Secretary sold 10,000 shares at an average $50.56 ($505,605)

From the SEC's structured data for this filing

Trades in this filing

Schuth Alexander O. · COO and Secretary

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-10-04 Sale : show line 1 in the form −5,994 $50.24 $301,139 477,089 I
2021-10-04 Sale : show line 2 in the form −4,006 $51.04 $204,466 473,083 I
Open-market sales · 10,000 sh · avg $50.56 · $505,605
Loading xslF345X03/wf-form4_163355842818926.xml…